U.S. FDA approves Novartis Leqvio to lower cholestrol

With two maintenance doses a year, Leqvio is the first and only FDA-approved small interfering RNA (siRNA) therapy for LDL-C (bad cholesterol) reduction1

A 39-year-old patient with Covid-19 was saved with ECMO support

Patient with acute Covid-19 infection treated at BGS Gleneagles Global Hospital

Astra Zeneca’s antibody combination to prevent Covid-19 neutralises Omicron variant

The study was performed independently by investigators at the US Food and Drug Administration (FDA), Center for Biologics Evaluation and Research

Six benefits of Cloud Computing in the pharma industry

ICMR Dibrugarh designs kit to detect Omicron variant in two hours

GCC Biotech is manufacturing the kits on a public-private partnership (PPP) model

Moderna announces positive interim Phase 1 data for mRNA flu vaccine

Phase 1 study of quadrivalent flu vaccine (mRNA-1010) successfully boosted titers against all four strains in older and younger adults, even at lowest dose; no significant safety concerns were observed

Medicago and GSK’s plant based Covid-19 vaccine candidate show promise in Phase 3 trials

Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants

Anaemia due to iron deficiency is a cause for concern in India

According to a survey conducted by FOGSI last year, 92% of the doctors opined that anaemia due to iron deficiency can be eradicated in five years

U.S. FDA grants breakthrough designation to Datar’s blood test to detect breast cancer

It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years

Indian Pharmacopoeia Commission revises and adds new impurities and IP reference standards

The Indian Pharmacopoeia Commission (IPC) has added 23 new impurities standards and 7 new Indian Pharmacopoeial Reference standards